Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Menopause

Novel menopause treatment rapidly reduces hot flashes

Research has shown that neurokinin 3 receptor antagonism has a rapid effect on vasomotor symptoms of menopause 

Vasomotor symptoms affect 70% of postmenopausal women and, along with sleep disturbance, are among the most bothersome reported symptoms.

In a placebo-controlled trial reported in Menopause (online, 12 March 2018), researchers explored the efficacy of a neurokinin 3 receptor antagonist known as MLE4901 on hot flashes in 37 women aged 40–62 years with vasomotor symptoms[1].

The team found that by day 3 of treatment, hot flash frequency had reduced in the active treatment group by 51 percentage points compared with placebo. Women who received MLE4901 also reported significant reductions in hot flash severity, interference with daily life, and improvements in sleep and concentration by day 3. These effects were sustained throughout the four-week study period.

The researchers concluded that the results indicate neurokinin 3 receptor antagonism has a rapid effect on vasomotor symptoms of menopause and could provide an effective alternative to oestrogen therapy.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2018.20204615

Readers' comments (1)

  • I had all wikipedia effects of neurokinin, during my menopause experience. Muscle spasms and twitching, gripes, uterine cramps, repeated transient B.P. elevations, acute post -flash diuresis, neurogenic bladder-like symptoms, memory issues, extremely lowered pain threshold-to the point that the touch of water turned unbearable, and much more. I would have been an ideal candidate for use of this Neurokinin antagonist. Neurokinin, however, has a critical role in the nervous, pulmonary, and cardiovascular systems, and also in inflammation and tissue repair, elimination of which could be possibly harmful. Admittedly thus, i could be hesitant to use it, particularly my being a physician!
    Maria Jasmine Freeman

    Unsuitable or offensive? Report this comment

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Wilting flower, menopause concept

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.